image: Octapharma USA presented research at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting evaluating the efficacy and safety of cutaquig® (Immune Globulin Subcutaneous ...
Morning Overview on MSN
A single gene-editing infusion cut severe swelling attacks by 87 percent in a trial
People living with hereditary angioedema, a rare genetic condition that triggers sudden, painful swelling of the face, throat ...
Morning Overview on MSN
A one-time CRISPR infusion cut hereditary swelling attacks by 87% in a first-ever trial
People living with hereditary angioedema, a rare genetic condition that triggers unpredictable and sometimes life-threatening ...
Facility-Level Disparities in Radiation Use for Limited-Stage Small Cell Lung Cancer Patient-controlled analgesia (PCA) has been considered for managing cancer pain; however, limited research has been ...
Longitudinal study of anti-myeloma treatment patterns in a U.S. commercial population before and after approval of bortezomib (BOR). The utility and prognostic value of positron emission tomography ...
After being found effective over longer durations with smaller doses, this study found that nipocalimab infusions resulted in a tolerable safety profile and remained effective even in shorter ...
The neonatal intensive care setting offers unique challenges when attempting to standardize drug concentrations. A diverse range of patients exists within a neonatal intensive care unit (NICU), from ...
FDA Warns of Serious Risks for Syringe Pumps at Low Infusion Rates The US Food and Drug Administration (FDA) on Thursday issued a warning to healthcare providers over serious adverse events tied to ...
With its high patient volume and mission to deliver comprehensive cancer care “from bed to bench” for each patient, University of California San Diego’s (UCSD) Moores Cancer Center prioritizes its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results